SCHEMBL12569733

SCHEMBL12569733

CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CON

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 15/20 0.64
MMP8 P22894 13/20 0.64
MMP1 P03956 6/20 0.64
MMP3 P08254 5/20 0.64
MMP2 P08253 16/20 0.63
MMP14 P50281 2/20 0.60
ADAM10 O14672 1/20 0.60
ADAM12 O43184 1/20 0.60
ADAMTS4 O75173 1/20 0.60
MMP7 P09237 1/20 0.60
MMP12 P39900 1/20 0.60
MMP13 P45452 1/20 0.60
MMP15 P51511 1/20 0.60
MMP16 P51512 1/20 0.60
ADAM17 P78536 1/20 0.60
ADAM9 Q13443 1/20 0.60
MMP26 Q9NRE1 1/20 0.60
MMP17 Q9ULZ9 1/20 0.60
ADAMTS5 Q9UNA0 1/20 0.60
P2RY14 Q15391 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30127790 0.88 MAPT (0.67) TP53
SCHEMBL26447749 0.88 MAPT (0.67) TP53
SCHEMBL21937712 0.88 MAPT (0.67) TP53
SCHEMBL21879062 0.88 KDM4E (0.66) P2RY14TP53POLB
SCHEMBL21879060 0.88 KDM4E (0.66) P2RY14TP53POLB
SCHEMBL30127707 0.88 KMT2A (0.71) P2RY14TP53POLB
SCHEMBL21937713 0.88 KMT2A (0.71) P2RY14TP53POLB
SCHEMBL21879133 0.87 POLB (0.70) P2RY14TP53POLB
SCHEMBL23960347 0.87 MMP9 (0.68) MMP9MMP8MMP1MMP3MMP2
SCHEMBL25139560 0.86 MMP9 (0.70) MMP9MMP8MMP1MMP3MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964410-B2 Method for preparing analysis sample, analysis sample and sugar chain capture agent SUMITOMO BAKELITE COMPANY, LTD. (JP) 2011-06-21 US disclosed
US-20090068752-A1 Method for Preparing Analysis Sample, Analysis Sample and Sugar Chain Capture Agent SUMITOMO BAKELITE COMPANY LIMITED (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068752-A1 Method for Preparing Analysis Sample, Analysis Sample and Sugar Chain Capture Agent SI, MGAM, GALE MMP9 2021/4885MMP8 1035/4885MMP1 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.